Mechanistic analysis showed that MSC-derived EVs inhibited the TGF-β1/SMAD family member 2 (SMAD2) signaling pathway, which played an important role in the EV-associated improvement in diabetes-induced myocardial injury and fibrosis [101]. Here, SMAD2 is linked to diabetes mellitus.